By combining exclusive early-stage access with public market investments, LabGold’s activist investments will give Shareholders exposure to a mix of liquid, undervalued public equities and ...
Patients in 200 mg BID cohort had median progression free survival of 6.2 months and median overall survival of 28.1 months, comparing favorably ...
A local organisation has completed the first part of a genetic project aimed at restoring the Bermuda cedar population. A ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback